| 000 | 01186 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250515080312.0 | ||
| 264 | 0 | _c20080317 | |
| 008 | 200803s 0 0 eng d | ||
| 022 | _a1084-9521 | ||
| 024 | 7 |
_a10.1016/j.semcdb.2007.06.006 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFingleton, Barbara | |
| 245 | 0 | 0 |
_aMMPs as therapeutic targets--still a viable option? _h[electronic resource] |
| 260 |
_bSeminars in cell & developmental biology _cFeb 2008 |
||
| 300 |
_a61-8 p. _bdigital |
||
| 500 | _aPublication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDrug Delivery Systems |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMatrix Metalloproteinase Inhibitors |
| 650 | 0 | 4 |
_aMatrix Metalloproteinases _xphysiology |
| 650 | 0 | 4 |
_aMetabolic Diseases _xdrug therapy |
| 650 | 0 | 4 | _aModels, Animal |
| 650 | 0 | 4 | _aTreatment Outcome |
| 773 | 0 |
_tSeminars in cell & developmental biology _gvol. 19 _gno. 1 _gp. 61-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.semcdb.2007.06.006 _zAvailable from publisher's website |
| 999 |
_c17224836 _d17224836 |
||